We describe a specific assay of 1,25-dihydroxy vitamin D3 in human serum, based on isotope dilution-mass fragmentography.
D3 as internal standard (15) (16) (17) .
The internal standard was added to serum before extraction and chromatographies, and it is assumed that the degradation or decomposition of this labeled standard was the same as the degradation of unlabeled 25-hydroxy vitamin D3. In the final mass-spectrometric step, the ratio between unlabeled and labeled molecules was determined with high accuracy. Such a specific method also is needed for 1,25-dihydroxy vitamin D3. Here, we report a mass-fragmentographic assay for 1,25-dihydroxy vitamin D3 in human serum, with [26-2H3] -1,25-dihydroxy vitamin D3 used as internal standard. with kidney homogenate from rachitic chicks (18, 19) . Kidneys from five chicks were homogenized (1 g/10 mL) in a medium (1/2 by vol). The 1,25-dihydroxy vitamin D3 obtained in the chloroform phase was purified by chromatography on Sephadex LH-20 and HPLC on Spherisorb silica and Spherisorb ODS-silica as described below for the serum samples. The ultraviolet spectrum disclosed that the final preparation was not entirely pure. Thus the trough normally seen at 228 nm was absent. The exact yield could not be determined, but was estimated to be about 2.5 Mg. No interfering compounds were seen, however, in the mass-fragmentographic assay ( Figure 3B ). According to the massfragmentographic analysis, the material contained 1.4% unlabeled 1, 25- (1/2), as described by Jones (13) .
Materials and Methods

Materials
The chloroform extract was concentrated to a small volume in a rotary evaporator at room temperature, 2-3 mL of methanol was added, and the solvent was removed under a stream of nitrogen. The residue was dissolved in 1 mL of hexane/methanol/chioroform, 9/1/1 (by vol) and chromatographed on a Sephadex LH 20 column, 10 X 150 mm (Pharmacia,Fine ChemicalsAB, Uppsala,Sweden),as described by Lambert et al. (20) . The fractions corresponding to eluted 1,25-dihydroxyvitamin D3 (as determined in separate runs, withbiosynthetically produced radiolabeled 1,25-dihydroxy vitamin D3 as marker) were collected. The solvent was evaporated under nitrogen and the residue was dissolved in 100 ILL of isopropanol/hexane (7.5/92.5 by vol). The entire sample was then chromatographed in a Spectra Physics 3500 B chromatographic system equipped with a Rheodyne Model 7120 injector, a 100-ILL sample loop, and a prepacked 4.6 X 250 mm column of Spherisorb 5-Mm (particle diameter) silica Phase Separations, Ltd., Queensferry, England. A fixed-wavelength (254-nm) ultraviolet detector, Spectra Physics Model 8200, was used to monitor eluted material. 1,25-Dihydroxy vitamin D3 was eluted at a flow rate of 2 mL/min with the isopropanol/hexane mixture. The appropriate fractions were collected, the solvent was evaporated under nitrogen, and the residue was dissolved in the solvent used for reversed-phase HPLC, for which we used a Spherisorb ODS-silica column and methanol/water (75/25 by vol) at a flow rate of 2.4 mL/min. One-minute fractions were collected, and two fractions containing 1,25-dihydroxy vitamin D3 were collected in each chromatographic run. After removal of the solvent, the material was converted into the trimethylsilyl ether (21) and dissolved in 25 1tL of hexane. Combined gas chromatography-mass spectrometry.
An LKB 2091 instrument equipped with a multiple ion detector was used. The gas chromatography was performed with a 1.5% SE-30 column (on Chromosorb W, 80-100 mesh, 2 mm X 1.5 m). The carrier gas was helium and the flow rate about 15 mL/min.
The temperature of the column was about 250 #{176}C and that of the ion source about 270 #{176}C. The electron energy was set at 3.2 aJ. The electron multiplier sensitivity was set to 500-600. The first channel of the multiple ion detector was focused on the ion at m/e 452, the second at m/e 455. In general, the amplification used for the first channel was 500X and for the second channel 200X. The peak heights of the recordings were measured because we found this gave more reproducible results than measurement of peak area. In some experiments, designed to test the specificity of the assay, the two channels were focused on the ions at rn/c 131 and 134.
Results
Figure 1 shows typical HPLC chromatograms
for [26-2H3J -1,25-dihydroxy vitamin D3, unlabeled 1,25-dihydroxy vitamin D3, and 1,25-dihydroxy vitamin D3 isolated from serum, to which deuterium-labeled 1,25-dihydroxy vitamin D3 had been added. As seen in the chromatogram shown in Figure 1C , the fractions obtained in the isolation of material from serum, contained some unidentified ultraviolet-absorbing compound(s) in addition to 1,25-dihydroxy vitamin D3. The purity was satisfactory, however, for the further analysis by gas chromatography-mass spectrometry. between C-24 and C-25 (15, 22, 23) .
With respect to sensitivity, the ion at rn/c 131 should be preferred. The specificity of a mass-fragmentographic assay, however, in general decreases with decreasing relative molecular mass of the fragment chosen for assay. Thus it was shown that use of the ion at rn/c 131 was sometimes complicated by interference (cf. below). Therefore we chose the ion at rn/c 452 for assay of 1,25-dihydroxy vitamin D3 in the standard procedure.
Typical multiple-ion detector recordings of the trimethylsilyl derivativeof unlabeled and deuterium-labeled 1,25-dihydroxy vitamin D3 are shown in Figure 3A and B, respec- tively. In accordance with previous work, two peaks were obtained, corresponding to the pyro and isopyro form, respectively (15, 24) . Only the pyro forms were used in the quanti- The accuracy of the technique was tested by assay of 1,25-dihydroxy vitamin D3 in sera to which a known amount of unlabeled 1,25-dihydroxy vitamin D3 had been added. As seen in Table 1 , there was a good agreement between expected and found value. The concentration of 1,25-dihydroxy vitamin D3 in sera from 15 healthy subjects was 55 10 ng/L (mean ± SD).
Discussion
To our knowledge, the concentration of 1,25-dihydroxy vitamin D3 in serum has not previously been determined with other methods than those based on receptor binding. Thus it is of interest to compare the results obtained by the present method with those obtained previously ( It may be pointed out that the present method is completely specific for the D3-form of the hormone. In most of the previous assays (6, 8, 9) , both 1,25-dihydroxy vitamin D3 and 1,25-dihydroxy vitamin D2 are determined simultaneously. It has been shown, however, that normally more than 90% of the circulating form of the hormone is 1,25-dihydroxy vitamin D3(7).
A serious drawback of the present method is the great amount of serum needed, 20 mL. Under optimal conditions, with the instrumentation used in the present work, it should be possible to reduce the amount of serum to about 5 mL. By use of capillary gas chromatography-mass spectrometry, the volume of serum may be reduced even more. Attempts further to improve the method with respect to volume of serum are in progress. 
